Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03678311 · ClinicalTrials.gov registry record · NA
Long QT Syndrome and Sleep Apnea
A NA study of Sleep Apnea and Long QT Syndrome, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT03678311 is a NA study of Sleep Apnea and Long QT Syndrome that has completed, run by The Cleveland Clinic. The registered enrollment target is 9 participants, below the 2,989-participant average among 36 other Sleep Apnea trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03678311, a NA study of Sleep Apnea and Long QT Syndrome, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
Obstructive sleep apnea (OSA) has been associated with cardiac repolarization abnormalities and implicated in sudden cardiac death. A biologically plausible mechanism by which OSA exerts this lethality is by QT interval prolongation, a known marker of ventricular tachyarrhythmias (VTA) leading to cardiac death. Congenital long QT syndrome (LQTS) is a familial arrhythmogenic disorder characterized by prolonged QT interval on the electrocardiogram and increased propensity for VTA. Preliminary data identify an association of the extent of severity of OSA and progressive prolongation of the corrected QT interval in LQTS.
Conditions Studied
Interventions
- DEVICE Continuous Positive Airway Pressure (CPAP)
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-03-13 |
| Est. Completion | 2019-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03678311
The ClinicalTrials.gov registry entry for NCT03678311 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,989-participant average among 36 other Sleep Apnea trials with a reported enrollment target (100% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which Continuous Positive Airway Pressure (CPAP) is the first listed.
NCT03678311 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT03678311 about?
NCT03678311 is a clinical study titled "Long QT Syndrome and Sleep Apnea". Obstructive sleep apnea (OSA) has been associated with cardiac repolarization abnormalities and implicated in sudden cardiac death. A biologically plausible mechanism by which OSA exerts this lethality is by QT interval prolongation, a known marker of ventricular tachyarrhythmias (VTA) leading to ca...
What is the current status of trial NCT03678311?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2019-03-13. Estimated completion is 2019-04-30.
What conditions does trial NCT03678311 study?
This clinical trial studies the following conditions: Sleep Apnea, Long QT Syndrome.
What interventions are being tested in trial NCT03678311?
The interventions under investigation include: Continuous Positive Airway Pressure (CPAP) (DEVICE).
Who is sponsoring clinical trial NCT03678311?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03678311 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mechanisms of Prediabetic States in Sleep Apnea
RECRUITING · NA
-
Reaching for Equity in Sleep Apnea Treatment (REST) Study
RECRUITING · NA
-
Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks
RECRUITING · NA
-
Effect of Hypercapnia Treatment on Respiratory Recovery After Spinal Cord Injury
RECRUITING · NA
-
Janus II Feasibility
RECRUITING · NA
-
Technology-Supported Treatment of Sleep Apnea in Prediabetes
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.